This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tyson Foods Grows on Rising Demand for Protein Products
by Zacks Equity Research
Tyson Foods (TSN) continues to deliver impressive performance, courtesy of strong consumer demand for protein packed food products.
Why Is Estee Lauder (EL) Up 4.5% Since Its Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.
Pinnacle Foods (PF) Lags on Q4 Earnings, Provides 2018 View
by Zacks Equity Research
The AJ exit and Boulder SKU rationalization negatively impact Pinnacle Foods (PF) fourth-quarter 2017 performance. However, benefits from the 53rd week aid the company's sales.
Can Robust Strategies Fuel Pinnacle Foods' (PF) Q4 Earnings?
by Zacks Equity Research
Pinnacle Foods' (PF) fourth-quarter 2017 results to gain from acquisitions, productivity enhancing and cost-saving initiatives. However, escalated marketing and freight costs are concerns.
Colgate (CL) Gains From Its Savings Plan: Time to Hold?
by Zacks Equity Research
Colgate (CL) benefits from progress of its savings program. However, strained margins remain a potent threat.
Clorox to Return More to Shareholders on Tax Reform Benefits
by Zacks Equity Research
Clorox (CLX) accelerated dividend increase announcement in order to reward shareholders with gains from the new tax reform. It raised quarterly dividend by 14% to 96 cents per share.
Coty (COTY) Jumps: Stock Rises 14.2%
by Zacks Equity Research
Coty (COTY) shares rose more than 14% in the last trading session, amid huge volumes.
Estee Lauder (EL) Beats on Q2 Earnings & Sales Estimates
by Zacks Equity Research
Estee Lauder (EL) came out with second-quarter fiscal 2018 results, wherein adjusted earnings of $1.52 per share beat the Zacks Consensus Estimate of $1.44.
EL Vs CLX: Which Stock is Poised for Better Q2 Earnings?
by Zacks Equity Research
The fourth-quarter earnings season has turned out to be pretty well so far. Estee Lauder and Clorox are likely to report their quarterly results tomorrow.
Can Ulta Beauty's (ULTA) Robust Strategies Offset Hurdles?
by Zacks Equity Research
Ulta Beauty (ULTA) has been gaining from its effective marketing initiatives, loyalty program and sturdy e-commerce business. However, stiff competition remains a threat.
Big Lots (BIG) Touches a 52-Week High: Can it Surge Higher?
by Zacks Equity Research
Big Lots (BIG) hit a 52-week high on Jan 26 driven by its robust initiatives and solid earnings history. Also, the company has shown impressive comps growth.
McCormick (MKC) Tops Q4 Earnings Estimates, Issues '18 View
by Zacks Equity Research
McCormick's (MKC) fourth-quarter earnings gain on acquisitions. Strong marketing and pricing actions fuel growth.
How MKC Will Contribute to Consumer Staples' Q4 Earnings Trend
by Zacks Equity Research
McCormick's (MKC) fourth-quarter results are expected to gain from business expansion and cost-saving efforts. However, rising input costs and marketing spend raise caution.
Positive Currency Rates to Aid Ralph Lauren (RL) Q3 Earnings
by Zacks Equity Research
Ralph Lauren's (RL) guidance clearly reflect the gains from recent positive movements in foreign currency rates. We expect the company to beat expectations when it reports third-quarter fiscal 2018 results on Feb 1.
Can Coty Continue Gaining From Buyouts & E-Commerce Growth?
by Zacks Equity Research
Coty (COTY) continues to gain from acquisitions and surging online business. However, headwinds in the Consumer Beauty segment mar organic sales.
What's in Store for Procter & Gamble (PG) in Q2 Earnings?
by Zacks Equity Research
Weak volumes and higher input cost might affect Procter & Gamble's (PG) results. However, share repurchases, focus on product innovations and reducing costs might improve margins.
Do Colgate's (CL) Strategies Indicate Earnings Beat in Q4?
by Zacks Equity Research
We expect Colgate(CL) to beat expectations when it reports fourth-quarter 2017 results on Jan 26. Innovation and in-store implementation have been the guiding principles for Colgate's growth strategy over the years.
Will McCormick's (MKC) Q4 Earnings Gain From Acquisitions?
by Zacks Equity Research
McCormick (MKC) is expected to gain from acquisitions and cost-saving initiatives during fourth-quarter fiscal 2017.
Is Whirlpool (WHR) Poised for Dismal Earnings Again in Q4?
by Zacks Equity Research
Whirlpool Corp. (WHR) is slated to release fourth-quarter 2017 results on Jan 24. The primary concern for the company in recent quarters has been raw material cost inflation and unfavorable price/mix.
Forget Archer Daniels, Buy These 3 Consumer Staples Stocks
by Zacks Equity Research
The Consumer Staples sector has been gaining from a buoyant U.S. economy. While Archer Daniels is battling several challenges, there are stocks gaining from the current economic trends.
Estee Lauder (EL) Up 61% in a Year: More Growth in Store?
by Zacks Equity Research
Solid fundamentals, combined with a positive outlook, uphold Estee Lauder's (EL) prospects for fiscal 2018.
SUPERVALU's Dismal Start in 2018 Gives Investors Cold Feet
by Zacks Equity Research
SUPERVALU's (SVU) persistent struggle with retail business weighs on investors' sentiments. However, stable wholesale business helps the company to stay afloat.
United Natural Up 27% in 6 Months: Further Upside in Store?
by Zacks Equity Research
United Natural's (UNFI) sales channels gain from high consumer demand for organic products. Further, the company has been widening distribution network and inducing growth.
Can Estee Lauder (EL) Keep the Earnings Streak Alive This Quarter?
by Zacks Equity Research
Estee Lauder (EL) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
Factors That are Likely to Fuel Kimberly-Clark (KMB) in 2018
by Zacks Equity Research
Kimberly-Clark's (KMB) continued focus on cost saving, innovation and restructuring is likely to aid growth in the forthcoming periods.